Related Experiment Video
Updated: Aug 13, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Surviving apoptosis
A T M Vaughan1, C J Betti, M J Villalobos
1Department of Radiation Oncology, Loyola University Medical Center, 2160 South First Avenue, Building 112, Maywood, Illinois 60153, USA. avaugha@lumc.edu
Abstract:
The concept that cells subjected to chromatin cleavage during apoptosis are destined to die is being challenged. The execution phase of apoptosis is characterized by the activation of effector caspases, such as caspase-3, that cleave key regulatory or structural proteins and in particular activate apoptotic nucleases such as the caspase activated deoxyribonuclease (CAD). It is apparent that caspases of this type may become active both through non-apoptotic processing and potentially within cells that exhibit apoptotic morphology but are subsequently able to survive. In such systems caspase suppressor molecules, the inhibitors of apoptotic proteins or IAP's, may rescue cells from apoptotic nuclease(s) attack initiated by transient caspase activation. The MLL gene is involved in leukemogenic translocations in ALL and AML and is a target of nuclease cleavage during apoptosis. Translocations initiated at the site of apoptotic nuclease attack within MLL have been identified and may offer a model, with clinical relevance, for DNA damage mediated by the apoptosis system in cells destined to survive. The specificity of apoptotic cleavage combined with the potential for recovery from the execution phase of apoptosis suggests a novel and pathogenic role for apoptosis in creating translocations with leukemogenic potential.
Insights
Cells surviving apoptosis can still undergo DNA damage, leading to leukemogenic translocations. This challenges the notion that chromatin cleavage during apoptosis always results in cell death.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Apoptosis involves chromatin cleavage by activated nucleases, like caspase-activated deoxyribonuclease (CAD).
- Caspase activation and subsequent nuclease activity are not always lethal, as cells can survive transient apoptotic signaling.
- Inhibitors of Apoptotic Programmed Cell Death Proteins (IAPs) can protect cells from nuclease-mediated damage.
Purpose of the Study:
- To investigate the role of apoptosis-associated DNA damage in generating leukemogenic translocations.
- To explore how cells surviving the apoptotic cascade can harbor DNA alterations.
- To examine the MLL gene as a potential target for apoptosis-mediated translocations.
Main Methods:
- Analysis of caspase activation and nuclease activity in cells undergoing transient apoptosis.
- Investigation of Inhibitors of Apoptotic Programmed Cell Death Proteins (IAPs) in cell survival.
- Identification of translocations within the MLL gene in relation to apoptotic nuclease attack.
Main Results:
- Demonstration that cells can survive caspase activation and nuclease activity despite apoptotic morphology.
- Identification of specific translocation breakpoints within the MLL gene at sites of apoptotic nuclease cleavage.
- Evidence suggesting that MLL gene translocations can arise from DNA damage during a potentially survivable apoptotic event.
Conclusions:
- Chromatin cleavage during apoptosis does not invariably lead to cell death.
- Transient caspase activation followed by recovery can result in DNA damage and oncogenic translocations.
- Apoptosis-mediated DNA damage, particularly in genes like MLL, represents a novel mechanism contributing to leukemogenesis.
Related Concept Videos
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy

